Geode Capital Management, LLC Kempharm, Inc Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Kempharm, Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 787,020 shares of KMPH stock, worth $3.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

787,020

Previous 729,179 7.93%

Holding current value

$3.89 Million

Previous $3.6 Million 7.91%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	N/A	57,841 Added 7.93%	787,020 $3.89 Million
Q4 2023 Feb 13, 2024	BUY	N/A	50,128 Added 7.38%	729,179 $3.6 Million
Q3 2023 Nov 13, 2023	BUY	N/A	7,475 Added 1.11%	679,051 $3.35 Million
Q2 2023 Aug 11, 2023	BUY	$4.94 - $6.29 $1.74 Million - $2.22 Million	352,558 Added 110.51%	671,576 $3.32 Million
Q1 2023 May 15, 2023	BUY	$4.13 - $6.27 $37,896 - $57,533	9,176 Added 2.96%	319,018 $1.75 Million

Q4 2022 Feb 13, 2023	BUY	$4.12 - $5.62 $21,382 - $29,167	5,190 Added 1.7%	309,842 $1.42 Million
Q3 2022 Nov 14, 2022	SELL	$4.5 - $6.85 $61,105 - $93,016	-13,579 Reduced 4.27%	304,652 $1.9 Million
Q2 2022 Aug 12, 2022	SELL	$4.02 - $5.21 $897,131 - $1.16 Million	-223,167 Reduced 41.22%	318,231 $1.42 Million
Q1 2022 May 13, 2022	BUY	$5.0 - $9.26 $179,355 - $332,165	35,871 Added 7.1%	541,398 $2.72 Million
Q4 2021 Feb 11, 2022	BUY	$7.6 - $10.26 $127,642 - $172,316	16,795 Added 3.44%	505,527 $4.4 Million
Q3 2021 Nov 12, 2021	BUY	$8.72 - $13.31 $138,456 - $211,336	15,878 Added 3.36%	488,732 $4.56 Million
Q2 2021 Aug 13, 2021	BUY	$8.52 - $15.47 $2.51 Million - $4.56 Million	294,874 Added 165.68%	472,854 $6.06 Million
Q1 2021 May 12, 2021	BUY	$5.6 - $13.47 $996,687 - $2.4 Million	177,980 New	177,980 $1.64 Million

Others Institutions Holding KMPH

# of Institutions

Shares Held

13.8M

Call Options Held

68.1K

Put Options Held

42K

View Full List

About KEMPHARM, INC

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

More about KMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Kempharm, Inc Transaction History